These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20955426)

  • 1. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke.
    Hayakawa K; Qiu J; Lo EH
    Ann N Y Acad Sci; 2010 Oct; 1207():50-7. PubMed ID: 20955426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Therapeutic Targeting of HMGB1 in Stroke.
    Tian X; Liu C; Shu Z; Chen G
    Curr Drug Deliv; 2017 Sep; 14(6):785-790. PubMed ID: 27501713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
    Sachdev U; Cui X; Tzeng E
    J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1: endogenous danger signaling.
    Klune JR; Dhupar R; Cardinal J; Billiar TR; Tsung A
    Mol Med; 2008; 14(7-8):476-84. PubMed ID: 18431461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4.
    Schiraldi M; Raucci A; Muñoz LM; Livoti E; Celona B; Venereau E; Apuzzo T; De Marchis F; Pedotti M; Bachi A; Thelen M; Varani L; Mellado M; Proudfoot A; Bianchi ME; Uguccioni M
    J Exp Med; 2012 Mar; 209(3):551-63. PubMed ID: 22370717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.
    Yan W; Chang Y; Liang X; Cardinal JS; Huang H; Thorne SH; Monga SP; Geller DA; Lotze MT; Tsung A
    Hepatology; 2012 Jun; 55(6):1863-75. PubMed ID: 22234969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of high mobility group box 1 (HMGB1) in cultured human periodontal ligament cells].
    Hasegawa N
    Kokubyo Gakkai Zasshi; 2008 Oct; 75(3):155-61. PubMed ID: 19044016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke.
    Richard SA; Sackey M; Su Z; Xu H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
    Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis].
    Tachibana M
    Yakugaku Zasshi; 2018; 138(2):143-148. PubMed ID: 29386427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
    Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
    Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-mobility group box-1 in sterile inflammation.
    Tsung A; Tohme S; Billiar TR
    J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of High Mobility Group Box-1 in Epileptogenesis.
    Fu L; Nishibori M
    Acta Med Okayama; 2019 Oct; 73(5):383-386. PubMed ID: 31649363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the high-mobility group box 1 protein-receptor for advanced glycation end-products signaling pathway in rats during neurogenesis after intracerebral hemorrhage.
    Lei C; Wu B; Cao T; Zhang S; Liu M
    Stroke; 2015 Feb; 46(2):500-6. PubMed ID: 25538203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 preconditioning: therapeutic application for a danger signal?
    Klune JR; Billiar TR; Tsung A
    J Leukoc Biol; 2008 Mar; 83(3):558-63. PubMed ID: 17938274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
    Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR
    Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HMGB1/RAGE in inflammatory cardiomyopathy.
    Volz HC; Kaya Z; Katus HA; Andrassy M
    Semin Thromb Hemost; 2010 Mar; 36(2):185-94. PubMed ID: 20414834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HMGB1 receptor RAGE mediates ischemic brain damage.
    Muhammad S; Barakat W; Stoyanov S; Murikinati S; Yang H; Tracey KJ; Bendszus M; Rossetti G; Nawroth PP; Bierhaus A; Schwaninger M
    J Neurosci; 2008 Nov; 28(46):12023-12031. PubMed ID: 19005067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.